Last reviewed · How we verify

NCT05420142

Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products

Completed Phase 2 Last updated 26 September 2022
What this trial tests

Phase 2 trial testing Net peripheral AA appearance following ingestion of 3 selected PPF products compared to whey in Aging in 9 participants. Completed in 31 July 2022.

Timeline
14 March 2022
Primary endpoint
12 May 2022
31 July 2022

Quick facts

Lead sponsorUniversity College Dublin
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment9
Start date14 March 2022
Primary completion12 May 2022
Estimated completion31 July 2022
Sites2 locations across Italy, Ireland

Drugs / interventions tested

Conditions studied

Sponsor

University College Dublin

Who can join

65 and older, any sex, with Aging or Undernutrition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the digestibility and efficacy of the study groups previously developed innovative plant-based protein and fibre products.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Peripheral Amino Acid Appearance Is Lower Following Plant Protein Fibre Products, Compared to Whey Protein and Fibre Ingestion, in Healthy Older Adults despite Optimised Amino Acid Profile.
    de Marco Castro E, Valli G, Buffière C, Guillet C, et al · · 2022 · cited 9× · PMID 36615694 · DOI 10.3390/nu15010035

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other University College Dublin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420142.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing